Skip to Main Content
Contribute Try STAT+ Today

Subscribe to STAT Plus

Exclusive analysis of biotech, pharma, and the life sciences

First 30 days free
Billed annually or $35
Get Started

What is STAT+?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What does STAT+ cover?

Here’s the breakdown:

Market-moving analysis of pharma and biotech — from startup funding to clinical trial readouts
Health Tech
Developments in health care and technology, including what's new in AI and the latest moves by tech giants
The intersection of Capitol Hill, regulatory agencies, and the life sciences
Reporting on scientific breakthroughs driving drug discovery and pipeline development

What's included with a subscription?

Enjoy an exclusive set of benefits, including:

Daily reporting and analysis
The most comprehensive industry coverage and analysis of the biotech, pharma and health tech industries
Subscriber-only newsletters
Two daily newsletters to brief you on the most important industry news of the day, plus breaking news alerts for need-to-know headlines
Exclusive industry events
Invitations to digital and in-person STAT+ events, plus early-bird access and discounts to industry events around the country
STAT+ Conversations
Pop-up events where you'll engage with our reporters or industry experts about the key story of the moment
The best reporters in the industry
Our STAT+ newsroom is comprised of some of the nation's most trusted and well-connected health care and financial journalists
And much more
Interviews with industry leaders, opinion pieces, and premium tools, like our CRISPR Trackr and Drug Pricing Policy Cheat Sheet

Try 30 days of STAT+ on us. Cancel anytime.

Still have questions? Read our FAQs.

Get Started